337 related articles for article (PubMed ID: 32630545)
21. Editorial: The Biological and Clinical Aspects of HLA-G.
LeMaoult J; Yan WH
Front Immunol; 2021; 12():649344. PubMed ID: 33679813
[No Abstract] [Full Text] [Related]
22. Molecular pathways: human leukocyte antigen G (HLA-G).
Curigliano G; Criscitiello C; Gelao L; Goldhirsch A
Clin Cancer Res; 2013 Oct; 19(20):5564-71. PubMed ID: 23897901
[TBL] [Abstract][Full Text] [Related]
23. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.
Agaugué S; Carosella ED; Rouas-Freiss N
Blood; 2011 Jun; 117(26):7021-31. PubMed ID: 21482709
[TBL] [Abstract][Full Text] [Related]
24. The dual role of HLA-G in cancer.
Rouas-Freiss N; Moreau P; LeMaoult J; Carosella ED
J Immunol Res; 2014; 2014():359748. PubMed ID: 24800261
[TBL] [Abstract][Full Text] [Related]
25. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients.
Sabbatino F; Liguori L; Polcaro G; Salvato I; Caramori G; Salzano FA; Casolaro V; Stellato C; Col JD; Pepe S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023239
[TBL] [Abstract][Full Text] [Related]
26. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
[TBL] [Abstract][Full Text] [Related]
27. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
Yie SM; Hu Z
Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
[TBL] [Abstract][Full Text] [Related]
28. Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface.
Moreau P; Dausset J; Carosella ED; Rouas-Freiss N
Biol Reprod; 2002 Nov; 67(5):1375-8. PubMed ID: 12390865
[TBL] [Abstract][Full Text] [Related]
29. HLA-G and inflammatory diseases.
Baricordi OR; Stignani M; Melchiorri L; Rizzo R
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):67-74. PubMed ID: 18691135
[TBL] [Abstract][Full Text] [Related]
30. New insights into HLA-G mediated tolerance.
Amodio G; Sales de Albuquerque R; Gregori S
Tissue Antigens; 2014 Sep; 84(3):255-63. PubMed ID: 25132109
[TBL] [Abstract][Full Text] [Related]
31. Application of human leukocyte antigen-G expression in the diagnosis of human cancer.
Shih IeM
Hum Immunol; 2007 Apr; 68(4):272-6. PubMed ID: 17400063
[TBL] [Abstract][Full Text] [Related]
32. Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.
Eichmüller SB; Osen W; Mandelboim O; Seliger B
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383653
[TBL] [Abstract][Full Text] [Related]
33. New Insights Into the Role of Qa-2 and HLA-G Non-classical MHC-I Complexes in Malignancy.
da Silva IL; Montero-Montero L; Ferreira E; Quintanilla M
Front Immunol; 2018; 9():2894. PubMed ID: 30574154
[TBL] [Abstract][Full Text] [Related]
34. Mouse models for studies of HLA-G functions in basic science and pre-clinical research.
Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Mulloy LL; Horuzsko A
Hum Immunol; 2016 Sep; 77(9):711-9. PubMed ID: 27085792
[TBL] [Abstract][Full Text] [Related]
35. HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies.
Morandi F; Airoldi I
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328349
[TBL] [Abstract][Full Text] [Related]
36. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
Agrawal S; Pandey MK
J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
[TBL] [Abstract][Full Text] [Related]
37. A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome.
van de Water RB; Krijgsman D; Houvast RD; Vahrmeijer AL; Kuppen PJK
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361031
[TBL] [Abstract][Full Text] [Related]
38. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
39. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival.
Menier C; Riteau B; Dausset J; Carosella ED; Rouas-Freiss N
Hum Immunol; 2000 Nov; 61(11):1118-25. PubMed ID: 11137216
[TBL] [Abstract][Full Text] [Related]
40. Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions.
Zhang X; Lin A; Han QY; Zhang JG; Chen QY; Ye YH; Zhou WJ; Xu HH; Gan J; Yan WH
Front Immunol; 2020; 11():565759. PubMed ID: 33329527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
